270 related articles for article (PubMed ID: 23469203)
21. Resveratrol induced serine phosphorylation of p53 causes apoptosis in a mutant p53 prostate cancer cell line.
Lin HY; Shih A; Davis FB; Tang HY; Martino LJ; Bennett JA; Davis PJ
J Urol; 2002 Aug; 168(2):748-55. PubMed ID: 12131363
[TBL] [Abstract][Full Text] [Related]
22. Resveratrol and pterostilbene as a microRNA-mediated chemopreventive and therapeutic strategy in prostate cancer.
Kumar A; Rimando AM; Levenson AS
Ann N Y Acad Sci; 2017 Sep; 1403(1):15-26. PubMed ID: 28662290
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of prostate cancer growth by muscadine grape skin extract and resveratrol through distinct mechanisms.
Hudson TS; Hartle DK; Hursting SD; Nunez NP; Wang TT; Young HA; Arany P; Green JE
Cancer Res; 2007 Sep; 67(17):8396-405. PubMed ID: 17804756
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic Potential of Gnetin C in Prostate Cancer: A Pre-Clinical Study.
Gadkari K; Kolhatkar U; Hemani R; Campanelli G; Cai Q; Kumar A; Levenson AS
Nutrients; 2020 Nov; 12(12):. PubMed ID: 33255879
[TBL] [Abstract][Full Text] [Related]
25. Metastasis-associated protein 1 inhibits p53-induced apoptosis.
Moon HE; Cheon H; Lee MS
Oncol Rep; 2007 Nov; 18(5):1311-4. PubMed ID: 17914590
[TBL] [Abstract][Full Text] [Related]
26. MTA1 drives malignant progression and bone metastasis in prostate cancer.
Kumar A; Dhar S; Campanelli G; Butt NA; Schallheim JM; Gomez CR; Levenson AS
Mol Oncol; 2018 Sep; 12(9):1596-1607. PubMed ID: 30027683
[TBL] [Abstract][Full Text] [Related]
27. Differential effects of resveratrol and its naturally occurring methylether analogs on cell cycle and apoptosis in human androgen-responsive LNCaP cancer cells.
Wang TT; Schoene NW; Kim YS; Mizuno CS; Rimando AM
Mol Nutr Food Res; 2010 Mar; 54(3):335-44. PubMed ID: 20077416
[TBL] [Abstract][Full Text] [Related]
28. A novel anti‑cancer effect of resveratrol: reversal of epithelial‑mesenchymal transition in prostate cancer cells.
Li J; Chong T; Wang Z; Chen H; Li H; Cao J; Zhang P; Li H
Mol Med Rep; 2014 Oct; 10(4):1717-24. PubMed ID: 25069516
[TBL] [Abstract][Full Text] [Related]
29. Gene profiling of MTA1 identifies novel gene targets and functions.
Ghanta KS; Li DQ; Eswaran J; Kumar R
PLoS One; 2011 Feb; 6(2):e17135. PubMed ID: 21364872
[TBL] [Abstract][Full Text] [Related]
30. Revelation of p53-independent function of MTA1 in DNA damage response via modulation of the p21 WAF1-proliferating cell nuclear antigen pathway.
Li DQ; Pakala SB; Reddy SDN; Ohshiro K; Peng SH; Lian Y; Fu SW; Kumar R
J Biol Chem; 2010 Mar; 285(13):10044-10052. PubMed ID: 20071335
[TBL] [Abstract][Full Text] [Related]
31. Metastasis-associated protein 1 drives tumor cell migration and invasion through transcriptional repression of RING finger protein 144A.
Marzook H; Li DQ; Nair VS; Mudvari P; Reddy SD; Pakala SB; Santhoshkumar TR; Pillai MR; Kumar R
J Biol Chem; 2012 Feb; 287(8):5615-26. PubMed ID: 22184113
[TBL] [Abstract][Full Text] [Related]
32. Resveratrol enhances antitumor activity of TRAIL in prostate cancer xenografts through activation of FOXO transcription factor.
Ganapathy S; Chen Q; Singh KP; Shankar S; Srivastava RK
PLoS One; 2010 Dec; 5(12):e15627. PubMed ID: 21209944
[TBL] [Abstract][Full Text] [Related]
33. Role of MTA1 in cancer progression and metastasis.
Sen N; Gui B; Kumar R
Cancer Metastasis Rev; 2014 Dec; 33(4):879-89. PubMed ID: 25344802
[TBL] [Abstract][Full Text] [Related]
34. Resveratrol sensitizes androgen independent prostate cancer cells to death-receptor mediated apoptosis through multiple mechanisms.
Gill C; Walsh SE; Morrissey C; Fitzpatrick JM; Watson RW
Prostate; 2007 Nov; 67(15):1641-53. PubMed ID: 17823925
[TBL] [Abstract][Full Text] [Related]
35. Dietary Pterostilbene for MTA1-Targeted Interception in High-Risk Premalignant Prostate Cancer.
Hemani R; Patel I; Inamdar N; Campanelli G; Donovan V; Kumar A; Levenson AS
Cancer Prev Res (Phila); 2022 Feb; 15(2):87-100. PubMed ID: 34675064
[TBL] [Abstract][Full Text] [Related]
36. Clinical implications of MTA proteins in human cancer.
Kaur E; Gupta S; Dutt S
Cancer Metastasis Rev; 2014 Dec; 33(4):1017-24. PubMed ID: 25374266
[TBL] [Abstract][Full Text] [Related]
37. DNA double-strand breaks lead to activation of hypermethylated in cancer 1 (HIC1) by SUMOylation to regulate DNA repair.
Dehennaut V; Loison I; Dubuissez M; Nassour J; Abbadie C; Leprince D
J Biol Chem; 2013 Apr; 288(15):10254-64. PubMed ID: 23417673
[TBL] [Abstract][Full Text] [Related]
38. Hepatitis B virus X protein induces the expression of MTA1 and HDAC1, which enhances hypoxia signaling in hepatocellular carcinoma cells.
Yoo YG; Na TY; Seo HW; Seong JK; Park CK; Shin YK; Lee MO
Oncogene; 2008 May; 27(24):3405-13. PubMed ID: 18264140
[TBL] [Abstract][Full Text] [Related]
39. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H; Stephens LC; Kumar R
Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
[TBL] [Abstract][Full Text] [Related]
40. Differential regulation of HIC1 target genes by CtBP and NuRD, via an acetylation/SUMOylation switch, in quiescent versus proliferating cells.
Van Rechem C; Boulay G; Pinte S; Stankovic-Valentin N; Guérardel C; Leprince D
Mol Cell Biol; 2010 Aug; 30(16):4045-59. PubMed ID: 20547755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
